by telrheum | Mar 16, 2024 | Biologic Therapy, Psoriatic Arthritis, Rheumatic Drugs, Spondyloarthritis
Bimekizumab, a novel biologic therapy, is showing promising results in the treatment of psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis (nr-axSpA, M46.80). This medication belongs to a class of drugs known as monoclonal...
by telrheum | Mar 16, 2024 | Biologic Therapy, Rheumatic Drugs, Rheumatoid Arthritis, Vaccines
The American College of Rheumatology (ACR) has provided guidance on the timing of COVID-19 booster vaccinations for patients undergoing biologic therapy. These recommendations are essential for ensuring that patients with rheumatic diseases, who are often on...
by telrheum | Mar 16, 2024 | Cybersecurity, Biologic Therapy, Rheumatic Drugs, Rheumatoid Arthritis
The Cybersecurity Incident at Change Healthcare Change Healthcare, a prominent player in the U.S. insurance claim processing sector, has experienced a cybersecurity breach, leading to significant disruptions in provider and pharmacy operations. This has affected the...
by telrheum | Mar 16, 2024 | Biologic Therapy, Rheumatic Drugs, Rheumatoid Arthritis, Vaccines
The American College of Rheumatology (ACR) has issued recommendations regarding the use of COVID-19 booster vaccines for patients undergoing biologic therapy, a treatment often prescribed for various autoimmune conditions, such as rheumatoid arthritis, psoriatic...
by telrheum | Mar 12, 2024 | Biologic Therapy, JAK Inhibitor, Rheumatic Drugs
Recent studies have hinted at the intriguing possibility that certain drugs used in the treatment of rheumatic diseases might also have beneficial effects in preventing or delaying the development of Alzheimer’s disease. This article delves into the emerging...
